These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24666527)

  • 1. Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder.
    Faria V; Ahs F; Appel L; Linnman C; Bani M; Bettica P; Pich EM; Wahlstedt K; Fredrikson M; Furmark T
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1149-57. PubMed ID: 24666527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder.
    Faria V; Appel L; Åhs F; Linnman C; Pissiota A; Frans Ö; Bani M; Bettica P; Pich EM; Jacobsson E; Wahlstedt K; Fredrikson M; Furmark T
    Neuropsychopharmacology; 2012 Sep; 37(10):2222-32. PubMed ID: 22617357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
    Frick A; Åhs F; Appel L; Jonasson M; Wahlstedt K; Bani M; Merlo Pich E; Bettica P; Långström B; Lubberink M; Fredrikson M; Furmark T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1775-1783. PubMed ID: 27642077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion Administration Increases Resting-State Functional Connectivity in Dorso-Medial Prefrontal Cortex.
    Rzepa E; Dean Z; McCabe C
    Int J Neuropsychopharmacol; 2017 Jun; 20(6):455-462. PubMed ID: 28340244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial.
    Lu L; Li H; Baumel WT; Mills JA; Cecil KM; Schroeder HK; Mossman SA; Huang X; Gong Q; Sweeney JA; Strawn JR
    Neuropsychopharmacology; 2022 Apr; 47(5):1081-1087. PubMed ID: 34580419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
    Lu L; Mills JA; Li H; Schroeder HK; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Ramsey LB; DelBello MP; Sweeney JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Oct; 60(10):1309-1318. PubMed ID: 33548492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor.
    Seedat S; Warwick J; van Heerden B; Hugo C; Zungu-Dirwayi N; Van Kradenburg J; Stein DJ
    J Affect Disord; 2004 May; 80(1):45-53. PubMed ID: 15094257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder.
    Dodhia S; Hosanagar A; Fitzgerald DA; Labuschagne I; Wood AG; Nathan PJ; Phan KL
    Neuropsychopharmacology; 2014 Aug; 39(9):2061-9. PubMed ID: 24594871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder.
    Frick A; Engman J; Alaie I; Björkstrand J; Gingnell M; Larsson EM; Eriksson E; Wahlstedt K; Fredrikson M; Furmark T
    J Affect Disord; 2020 Jan; 261():230-237. PubMed ID: 31655378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The common traits of the ACC and PFC in anxiety disorders in the DSM-5: meta-analysis of voxel-based morphometry studies.
    Shang J; Fu Y; Ren Z; Zhang T; Du M; Gong Q; Lui S; Zhang W
    PLoS One; 2014; 9(3):e93432. PubMed ID: 24676455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.
    Paulus MP; Feinstein JS; Castillo G; Simmons AN; Stein MB
    Arch Gen Psychiatry; 2005 Mar; 62(3):282-8. PubMed ID: 15753241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanfacine modulates the emotional biasing of amygdala-prefrontal connectivity for cognitive control.
    Schulz KP; Clerkin SM; Newcorn JH; Halperin JM; Fan J
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1444-53. PubMed ID: 25059532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study.
    Ruhé HG; Booij J; Veltman DJ; Michel MC; Schene AH
    J Clin Psychiatry; 2012 Apr; 73(4):451-9. PubMed ID: 21903032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.
    Simmons AN; Arce E; Lovero KL; Stein MB; Paulus MP
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1009-20. PubMed ID: 19545475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial.
    Gingnell M; Frick A; Engman J; Alaie I; Björkstrand J; Faria V; Carlbring P; Andersson G; Reis M; Larsson EM; Wahlstedt K; Fredrikson M; Furmark T
    Br J Psychiatry; 2016 Sep; 209(3):229-35. PubMed ID: 27340112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder.
    Whalen PJ; Johnstone T; Somerville LH; Nitschke JB; Polis S; Alexander AL; Davidson RJ; Kalin NH
    Biol Psychiatry; 2008 May; 63(9):858-63. PubMed ID: 17964548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.
    Andreescu C; Sheu LK; Tudorascu D; Gross JJ; Walker S; Banihashemi L; Aizenstein H
    Am J Geriatr Psychiatry; 2015 Feb; 23(2):200-14. PubMed ID: 24996397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.